LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $203,000 | -45.1% | 1,612 | -28.1% | 0.00% | -50.0% |
| Q1 2018 | $370,000 | +28.9% | 2,242 | +7.1% | 0.00% | 0.0% |
| Q4 2017 | $287,000 | -20.1% | 2,093 | -20.6% | 0.00% | 0.0% |
| Q3 2017 | $359,000 | +6.2% | 2,637 | -5.1% | 0.00% | 0.0% |
| Q2 2017 | $338,000 | +19.9% | 2,780 | +4.5% | 0.00% | 0.0% |
| Q1 2017 | $282,000 | -48.3% | 2,660 | -50.4% | 0.00% | -33.3% |
| Q4 2016 | $545,000 | +1.1% | 5,366 | +1.5% | 0.00% | 0.0% |
| Q3 2016 | $539,000 | -16.8% | 5,289 | -2.8% | 0.00% | -25.0% |
| Q2 2016 | $648,000 | +14.3% | 5,441 | +2.6% | 0.00% | 0.0% |
| Q1 2016 | $567,000 | +70.8% | 5,305 | +72.5% | 0.00% | +100.0% |
| Q4 2015 | $332,000 | -75.4% | 3,076 | -84.7% | 0.00% | -60.0% |
| Q1 2014 | $1,348,000 | – | 20,057 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |